Learn how you can manage and alleviate your current side effects while actively working to prevent a relapse or secondary cancer using evidence-based, non-toxic therapies.
Click the orange button to the right to learn more.
“Doubled the length of time before their disease worsened” sounds great until you read that the article linked and excerpted below is talking about doubling 5.5 months to 11.4 months. My point is not that Sutent is a wonder drug for pancreatic cancer patients. My point is to draw your attention to therapy that “cuts off the supply of nutrients to tumors shows promise for treating people with the rare type of pancreatic cancer…”
I am a survivor of a different but equally complicated cancer called multiple myeloma. I have remained in complete remission from my MM by living an evidence-based, non-conventional, anti-MM lifestyle.
Angiogenesis is a central aspect of my non-toxic therapies. Anti-angiogenic nutrition, and anti-angiogenic supplementation specifically.
To learn more about the anti-cancer properties of angiogenesis- see the posts below-
Have you been diagnosed with pancreatic cancer? If so, what therapies are you considering? Please scroll down the page, post a question or a comment and I will reply to you ASAP.
“Pancreatic neuroendocrine tumors– In November 2010, Sutent gained approval from the European Commission for the treatment of ‘unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumors with disease progression in adults’. In May 2011, the USFDA approved Sunitinib for treating patients with ‘progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body (metastatic)’.“